Supplemental Figure 3a from PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

MLA

Michael F. Press, et al. Supplemental Figure 3a from PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22458981.v1.

APA

Michael F. Press, Dennis J. Slamon, John Mackey, Valerie Bee, Paolo Nuciforo, John Crown, Nicholas Robert, Miguel Martin, Tadeusz Pienkowski, Wolfgang Eiermann, Ivonne Villalobos, Angela Santiago, Gary A. Pestano, Mark R. Lackner, Carol O’Brien, Wafaa Elatre, Tomasz Burzykowski, Humphrey Gardner, & Howard M. Stern. (2023). Supplemental Figure 3a from PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance. https://doi.org/10.1158/1078-0432.22458981.v1

Chicago

Michael F. Press, Dennis J. Slamon, John Mackey, Valerie Bee, Paolo Nuciforo, John Crown, Nicholas Robert, et al. 2023. “Supplemental Figure 3a from PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance,” March. doi:10.1158/1078-0432.22458981.v1.